A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies

Helicobacter

Volumn 21, Issue 1, 2016, Pages 11-23

  Sun, Jing ^a   Rangan, Pooja ^a   Bhat, Srinidhi Subraya ^a   Liu, Longjian ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

Helicobacter pylori; Cardio vascular risk factor; Meta analysis

Indexed keywords

CAGA PROTEIN;

BACTERIAL STRAIN; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HEART DEATH; HELICOBACTER INFECTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; COMPLICATION; CORONARY ARTERY DISEASE; HELICOBACTER PYLORI; META ANALYSIS; MICROBIOLOGY; PHYSIOLOGY; RISK FACTOR;

CORONARY ARTERY DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84958892676     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12234     Document Type: Review

References (55)

1. Vlodaer Z, Garry DJ, Wilson R, eds. Coronary Heart Disease. New York: Springer, 2012.
2. Padmavati S, Gupta U, Agarwal HK. Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae. Indian J Med Res 2012;135:228-32.
3. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997;336:1014-6.
4. Wang SK, Wang JZ. Meta-analysis on the relationship of Chlamydia pneumonia infection and coronary heart disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2005;27:349-53.
5. Kendall TJ, Wilson JE, Radio SJ, et al. Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant 1992;11(3 Pt 2):S14-20.
6. Rogha M, Nikvarz M, Pourmoghaddas Z, Shirneshan K, Dadkhah D, Pourmoghaddas M. Is Helicobacter pylori infection a risk factor for coronary heart disease? ARYA Atheroscler 2012;8:5-8.
7. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001;103:45-51.
8. Khodaii Z, Vakili H, Ghaderian SM, Najar RA, Panah AS. Association of Helicobacter pylori infection with acute myocardial infarction. Coron Artery Dis 2011;22:6-11.
9. Rozankovic PB, Huzjan AL, Cupic H, Bencic IJ, Basic S, Demarin V. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease. J Neurol 2011;258:753-61.
10. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, Marz W, Pepys MB, Brenner H. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999;100:2326-31.
11. Danesh J, Wong Y, Ward M, Muir J. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 1999;81:245-7.
12. Rogha M, Dadkhah D, Pourmoghaddas Z, Shirneshan K, Nikvarz M, Pourmoghaddas M. Association of Helicobacter pylori infection with severity of coronary heart disease. ARYA Atheroscler 2012;7:138-41.
13. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J 1999;138:S434-7.
14. Danesh J, Wong Y, Ward M, Muir J. Risk factors for coronary heart disease and persistent infection with Chlamydia pneumoniae or cytomegalovirus: a population-based study. J Cardiovasc Risk 1999;6:387-90.
15. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336-41.
17. Stroup D, Berlin JA, Morton SC, Ingram Olkin, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
18. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20(3 Suppl):21-35.
19. Altman DG. Pratical Statistics for Medical Research. London: Chapman and Hall, 1991.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
21. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
22. Singh RK, McMahon AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 2002;88:43-6.
23. Ikeda A, Iso H, Sasazuki S, Inoue M, Tsugane S, JPHC Study Group. The combination of Helicobacter pylori -and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study. Atherosclerosis 2013;230:67-72.
24. Schöttker B, Adamu MA, Weck MN, Müller H, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 2012;220:569-74.
25. Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010;212:321-6.
26. Rizzo M, Corrado E, Coppola G, Muratori I, Novo S. Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein. J Investig Med 2008;56:32-40.
27. Stone AF, Risley P, Markus HS, Butland BK, Strachan DP, Elwood PC, Mendall MA. Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study. Heart 2001;86:506-9.
28. Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton J. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000;101:1647-52.
29. Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, Ellenga-Mbolla B, Vangu DN, Fuele SM. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. Vasc Health Risk Manag 2012;6:455-61.
30. Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O'Donnell CJ, Levy D. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002;40:1408-13.
31. Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: the Busselton Health Study. Eur J Cardiovasc Prev Rehabil 2003;10:278-82.
32. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JW, Sweetnam PM, Elwood PC. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation 1998;98:1286-90.
33. Stefler D, Bhopal R, Fischbacher CM. Might infection explain the higher risk of coronary heart disease in South Asians? Systematic review comparing prevalence rates with white populations in developed countries. Public Health 2012;126:397-409.
34. Manolakis A, Kapsoritakis AN, Potamianos SP. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter 2007;12:287-97.
35. Vizzardi E, Bonadei I, Piovanelli B, Quinzani F, Ricci C, Lanzini A, Dei Cas L. Helicobacter pylori and ischemic heart disease. Panminerva Med 2011;53:193-202.
36. Fabijanic D, Banic M, Kardum D, Sutlic Z, Radic M, Rudez I, Biocina B. Gastroduodenal lesions in coronary artery disease patients. Frequency, endoscopic characteristics and risk factors. Saudi Med J 2007;28:1137-9.
37. Banic M, Fabijanic D, Kardum D, Anic B, Sutlic Z, Romic Z, Petricusic L, Bonacin D, Kujundzic M. Gastroduodenal mucosal lesions and coronary atherosclerosis severity in patients with coronary artery disease. Lijec Vjesn 2008;130:228-33.
38. Tan HJ, Goh KL. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review J Dig Dis 2012;13:342-9.
39. Berrutti M, Pellicano R, Fagoonee S, Astegiano M, Smedile A, Saracco G, Repici A, Leone N, Rizzetto M. Potential relationship between Helicobacter pylori and ischemic heart disease: any pathogenic model? Panminerva Med 2008;50:161-3.
40. Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A Helicobacter pylori and extragastric diseases. Helicobacter 2014;19(Suppl 1):52-8.
41. Liu J, Wang F, Shi S. Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20, 000 participants. Helicobacter, 2014; doi: 10.1111/hel.12188. [Epub ahead of print]
42. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J 2006;151:1215-22.
43. Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009;202:535-42.
44. Ikeda H, Sato Y, Yoneda N, Harada K, Sasaki M, Kitamura S, Sudo Y, Ooi A, Nakanuma Y. alpha-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Hum Pathol 2012;43:1955-63.
45. Eskandarian R, Ghorbani R, Shiyasi M, Momeni B, Hajifathalian K, Madani M. Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study. Cardiovasc J Afr 2012;23:131-5.
46. Lentine KL, Parsonnet J, Taylor I, Wrone EM, Lafayette RA. Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin Exp Nephrol 2006;10:55-62.
47. Choussat R, Montalescot G, Collet J, Jardel C, Ankri A, Fillet A, Thomas D, Raymond J, Bastard J, Drobinski G, Orfila J, et al. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol 2000;86:379-84.
48. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, Anderson JL. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000;102:1917-23.
49. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J, AutoGene Investigators. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001;104:25-31.
50. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997;314:1317-8.
51. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999;131:573-7.
52. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 1997;315:1199-201.
53. Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
54. Witherell HL, Smith KL, Friedman GD, Ley C, Thom DH, Orentreich N, Vogelman JH, Parsonnet J. C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction. Ann Epidemiol 2003;13:170-7.
55. Folsom AR, Nieto J, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 1998;98:845-50.